biomarker
SphingoTec’s PenKid leads the way in early detection of delayed graft function after kidney transplant
July 1, 2025Medical Communications, Research and Development Nephrology, PenKid, SphingoTec, biomarker, clinical trial, delayed graft function, kidney replacement therapy, kidney transplant, serum creatinine
SphingoTec has announced new findings validating the clinical utility of its kidney biomarker proenkephalin A 119-159 (PenKid) in assessing graft …
Blood biomarker discovered that can predict COVID-19 infection
July 20, 2021Manufacturing and Production, Research and Development COVID-19. blood testing, biomarker, gene
Researchers have identified a gene, IFI27, that becomes activated in early stages of COVID-19 even when symptoms are absent, helping …
MSD receives first FDA approval based on specific genetic feature
May 24, 2017Research and Development, Sales and Marketing MSD, Precision Medicine, biomarker, keytruda
In a historic first, MSD (known as Merck in North America) has received approval for its immunotherapy treatment Keytruda in …
Merck receives CE Mark approval for new liquid biopsy test for colorectal cancer
April 6, 2016Medical Communications, Research and Development, Sales and Marketing CE Mark, Merck, biomarker, biopsy, colorectal cancer, liquid biopsy, ras, sysmex inostics
Merck (ETR: MRK) has announced that their new liquid biopsy RAS biomarker test for metastatic colorectal cancer, developed in collaboration …
